Literature DB >> 23145214

The Measurement to Understand Reclassification of Disease of Cabarrus/Kannapolis (MURDOCK) Study Community Registry and Biorepository.

Sayanti Bhattacharya1, Ashley A Dunham, Melissa A Cornish, Victoria A Christian, Geoffrey S Ginsburg, Jessica D Tenenbaum, Meredith L Nahm, Marie Lynn Miranda, Robert M Califf, Rowena J Dolor, L Kristin Newby.   

Abstract

Current understanding of chronic diseases is based on crude clinical characterization, imaging studies, and laboratory testing that has evolved over decades. The Measurement to Understand Reclassification of Disease of Cabarrus/Kannapolis (MURDOCK) Study is a multi-tiered, longitudinal study designed to enable classification of chronic diseases using clinically annotated biospecimen collections, -omic technologies, electronic health records, and standard epidemiological methods. We expect that detailed molecular classification will improve mechanistic understanding of chronic diseases, augmenting discovery and testing of new treatments, and allowing refined selection of prevention and treatment strategies. The MURDOCK Study Community Registry and Biorepository will serve as a bridge for validation of initial exploratory studies, a platform for future prospective studies in targeted populations, and a resource of both data (analytical and clinical) and samples for cross-registry meta-analyses and comparative population studies. Participation of local health care providers and the Cabarrus County/Kannapolis, NC, community will facilitate future medical research and provide the opportunity to educate and inform the public about genomic research, actively engaging them in shaping the future of medical discovery and treatment of chronic diseases. We present the rationale and study design for the MURDOCK Community Registry and Biorepository and baseline characteristics of the first 6000 participants.

Entities:  

Keywords:  Disease reclassification; biorepository; community registry

Year:  2012        PMID: 23145214      PMCID: PMC3493022     

Source DB:  PubMed          Journal:  Am J Transl Res            Impact factor:   4.060


  23 in total

1.  Recruitment and retention of minority women in cancer screening, prevention, and treatment trials.

Authors:  D R Brown; M N Fouad; K Basen-Engquist; G Tortolero-Luna
Journal:  Ann Epidemiol       Date:  2000-11       Impact factor: 3.797

2.  Risk stratification and therapeutic decision making in acute coronary syndromes.

Authors:  E M Ohman; C B Granger; R A Harrington; K L Lee
Journal:  JAMA       Date:  2000-08-16       Impact factor: 56.272

3.  The Framingham Offspring Study. Design and preliminary data.

Authors:  M Feinleib; W B Kannel; R J Garrison; P M McNamara; W P Castelli
Journal:  Prev Med       Date:  1975-12       Impact factor: 4.018

4.  The Women's Health Initiative recruitment methods and results.

Authors:  Jennifer Hays; Julie R Hunt; F Allan Hubbell; Garnet L Anderson; Marian Limacher; Catherine Allen; Jacques E Rossouw
Journal:  Ann Epidemiol       Date:  2003-10       Impact factor: 3.797

5.  UK Biobank: a project in search of a protocol?

Authors:  Virginia Barbour
Journal:  Lancet       Date:  2003-05-17       Impact factor: 79.321

Review 6.  Securing our genetic health: engendering trust in UK Biobank.

Authors:  Alan Petersen
Journal:  Sociol Health Illn       Date:  2005-03

7.  UK Biobank: from concept to reality.

Authors:  William Ollier; Tim Sprosen; Tim Peakman
Journal:  Pharmacogenomics       Date:  2005-09       Impact factor: 2.533

8.  Epidemiological approaches to heart disease: the Framingham Study.

Authors:  T R DAWBER; G F MEADORS; F E MOORE
Journal:  Am J Public Health Nations Health       Date:  1951-03

9.  Prediction of coronary heart disease using risk factor categories.

Authors:  P W Wilson; R B D'Agostino; D Levy; A M Belanger; H Silbershatz; W B Kannel
Journal:  Circulation       Date:  1998-05-12       Impact factor: 29.690

10.  The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators.

Authors: 
Journal:  Am J Epidemiol       Date:  1989-04       Impact factor: 4.897

View more
  18 in total

Review 1.  A Guide for a Cardiovascular Genomics Biorepository: the CATHGEN Experience.

Authors:  William E Kraus; Christopher B Granger; Michael H Sketch; Mark P Donahue; Geoffrey S Ginsburg; Elizabeth R Hauser; Carol Haynes; L Kristin Newby; Melissa Hurdle; Z Elaine Dowdy; Svati H Shah
Journal:  J Cardiovasc Transl Res       Date:  2015-08-14       Impact factor: 4.132

2.  Data Profiling in Support of Entity Resolution of Multi-Institutional EHR Data.

Authors:  Pei Wang; Daniel Pullen; Maryam Garza; Anita Walden; Meredith Zozus
Journal:  Stud Health Technol Inform       Date:  2019

3.  A comparison of neuropsychological performance between US and Russia: preparing for a global clinical trial.

Authors:  Kathleen M Hayden; Oksana A Makeeva; L Kristin Newby; Brenda L Plassman; Valentina V Markova; Ashley Dunham; Heather R Romero; Zarui A Melikyan; Cassandra M Germain; Kathleen A Welsh-Bohmer; Allen D Roses
Journal:  Alzheimers Dement       Date:  2014-07-22       Impact factor: 21.566

4.  Age-Related Adverse Inflammatory and Metabolic Changes Begin Early in Adulthood.

Authors:  Daniel Parker; Richard Sloane; Carl F Pieper; Katherine S Hall; Virginia B Kraus; William E Kraus; Janet L Huebner; Olga R Ilkayeva; James R Bain; L Kristin Newby; Harvey Jay Cohen; Miriam C Morey
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2019-02-15       Impact factor: 6.053

5.  Comparison of GC-MS and GC×GC-MS in the analysis of human serum samples for biomarker discovery.

Authors:  Jason H Winnike; Xiaoli Wei; Kevin J Knagge; Steven D Colman; Simon G Gregory; Xiang Zhang
Journal:  J Proteome Res       Date:  2015-03-16       Impact factor: 4.466

6.  Metabolome-based signature of disease pathology in MS.

Authors:  S L Andersen; F B S Briggs; J H Winnike; Y Natanzon; S Maichle; K J Knagge; L K Newby; S G Gregory
Journal:  Mult Scler Relat Disord       Date:  2019-03-09       Impact factor: 4.339

7.  The Cabarrus County COVID-19 Prevalence and Immunity (C3PI) Study: design, methods, and baseline characteristics.

Authors:  Coralei E Neighbors; Angie E Wu; Douglas G Wixted; Brooke L Heidenfelder; Carla A Kingsbury; Heidi M Register; Raul Louzao; Richard Sloane; Julie Eckstrand; Carl C Pieper; Richard A Faldowski; Thomas N Denny; Christopher W Woods; L Kristin Newby
Journal:  Am J Transl Res       Date:  2022-08-15       Impact factor: 3.940

8.  Improving population representation through geographic health information systems: mapping the MURDOCK study.

Authors:  Ben W Strauss; Ellis M Valentiner; Sayanti Bhattacharya; Michelle M Smerek; Ashley A Dunham; L Kristin Newby; Marie Lynn Miranda
Journal:  Am J Transl Res       Date:  2014-07-18       Impact factor: 4.060

9.  Physical Performance Across the Adult Life Span: Correlates With Age and Physical Activity.

Authors:  Katherine S Hall; Harvey J Cohen; Carl F Pieper; Gerda G Fillenbaum; William E Kraus; Kim M Huffman; Melissa A Cornish; Andrew Shiloh; Christy Flynn; Richard Sloane; L Kristin Newby; Miriam C Morey
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2017-04-01       Impact factor: 6.053

10.  Expanding the National Drug Abuse Treatment Clinical Trials Network to address the management of substance use disorders in general medical settings.

Authors:  Betty Tai; Steven Sparenborg; Udi E Ghitza; David Liu
Journal:  Subst Abuse Rehabil       Date:  2014-07-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.